Simplifying cell expansion and harvest at industrial scale using low-footprint scale-X™ carbo bioreactors
Efficient expansion of adherent mammalian cells remains a critical bottleneck in the production of viral vaccines and advanced therapy medicinal products (ATMPs). Traditional seed train workflows are labor-intensive, time-consuming, and difficult to scale.
This application note presents an optimized, automated approach using the scale-X™ platform and cell collect module to streamline seed train operations, reduce risks, and enable efficient scale-up to industrial bioreactors.
What you’ll learn
- How to reduce seed train timelines to just 4 days without compromising yield or performance
- How to achieve 96–99% cell viability with consistent single-cell recovery
- How to cut harvest volumes by up to ~70% vs. conventional flatware, simplifying downstream operations
Get the full data and process insights to optimize your adherent cell expansion strategy and scale efficiently.